awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38349213-31ECDE34-134B-4C1D-B0E0-B186619F0400
Q38349213-31ECDE34-134B-4C1D-B0E0-B186619F0400
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38349213-31ECDE34-134B-4C1D-B0E0-B186619F0400
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?
P2860
Q38349213-31ECDE34-134B-4C1D-B0E0-B186619F0400
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38349213-31ECDE34-134B-4C1D-B0E0-B186619F0400
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb204dca5490544e2894e61856e7d5db331b9043
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.